Litigation

Recent Posts

Medtronic Escapes Fraud Claims In Off-Label Stent Litigation
Posted on 28 Jul 2011 by Tom Moylan

BOSTON - (Mealey's) Finding that two whistle-blowers' False Claims Act (FCA) allegations failed to meet federal pleading requirements for fraud, a Massachusetts federal judge on July 27 dismissed claims that Medtronic Inc. promoted biliary stents... Read More